It is official, Manchester United have reached an agreement to sign Antony from Ajax for a fee of roughly £85 million. A statement from Ajax confirms that the club will receive €95 million (£81 million) upfront with up to €5 million (£4 million) in add-ons still to come. Both sides note that the deal is subject to a medical and international clearance
Fabrizio Romano has chimed in on the deal, adding that the player has signed a contract to stay at Old Trafford until 2027, with an option to extend this for another year.
Antony to Join Manchester United in £85 Million Deal
OFFICIAL: Ajax and Manchester United have reached an agreement for the transfer of Antony.
Transfer fee: €95M. Including add-ons, the fee could rise until €100M. pic.twitter.com/A1SHKFzTu1
— 𝐀𝐅𝐂 𝐀𝐉𝐀𝐗 💎 (@TheEuropeanLad) August 30, 2022
Statement Signing
Erik ten Hag and his side didn’t get off to the best of starts this season. An embarrassing 4-0 defeat to Brentford has sparked some life into the team as they have since completed the massive signings of former Real Madrid star Casemiro and have now acquired Antony.
Read More: After Casemiro: Manchester United Planning on Huge £126.5 Million Spend for Erik ten Hag
These two additions can go a long way to filling fans with the hope of good things to come this season, and they are already starting to get excited.
Dangerous Attacker
The 22-year-old is an attacking threat that should help propel the Red Devils forward. Not only can he score goals but he is a creative force who will no doubt work well with the other attacking options at the club. If he can come anywhere close to replicating his form for Ajax then Reds’ fans will be happy.
Read More: Premier League Predictions for Matchweek 5
Despite only spending two full seasons with the Dutch champions, the Brazilian attacker scored 25 goals. He netted 11 times in 46 appearances in his debut campaign but improved on this strike rate greatly the next year. In the 2021/22 term, he scored 12 times in just 33 appearances, proving to be much more efficient and clinical than the prior year.
